Strategies and challenges for the next generation of antibody–drug conjugates

By A. Beck, L. Goetsch, Charles Dumontet, N. Corvaïa. Nature reviews. Drug discovery, 2017

1,923 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/3131589a13a02648e41d17e7247acbdfc1864647

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Shi
2. Shijun Li
3. Zhiwen Fu
4. Yu Zhang
5. Sifei Han

Citations in the corpus

• Antibody drug conjugate: the “biological missile” for targeted cancer therapy (2022, background): “hematological malignancies.(26) Driven by fundamental research in oncology and immunology, the selection of ADC target antigen has gradually extended from conventional tumor cell antigens to targets in the tumor microenvironment, e.”